|
|
| date |  | | | title / topic / summary | sort by topic |
|---|
|
| 11/26/2001 | | | | Third Manhattan Alzheimer's Disease Conference, Sponsored by Nymox Pharmaceutical Corp., to be Held in New York on November 28
topic: R&D: Alzheimer's Disease Treatments
November 26, 2001: The Third Manhattan Alzheimer's Disease Conference will be held in New York City on November 28, 2001. The meeting is sponsored by Nymox Pharmaceutical Corporation (NASDAQ: NYMX). The Third Manhattan Alzheimer Disease Conference will feature world class experts and speakers on a broad range of medical, social, economic and legal issues surrounding the diagnosis, treatment, and care of Alzheimer's disease patients. |
| 11/09/2001 | | | | Nymox's AlzheimAlert™ To Be Presented at the Annual Meeting of the Society for Neuroscience
topic: AlzheimAlert™ & Diagnosis of Alzheimer's Disease
November 9, 2001: Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today that positive results of another successful clinical study of the Company's AlzheimAlert™ test will be reported in a platform presentation at the 31st Annual Meeting of the Society for Neuroscience on November 11 in San Diego, California. Gregory Golden Ph.D. of the Alzheimer's Center, Coatesville, Pennsylvania and Thomas Jefferson University will present the paper on the study. The results of the multi-center double-blind retrospective study show that AlzheimAlert™ can accurately distinguish between patients with Alzheimer's disease and healthy subjects. |
| 11/08/2001 | | | | Nymox Technology Highlighted in Science Magazine
topic: R&D: Alzheimer's Disease Treatments
Nov. 8, 2001: The neuroscience drug discovery and diagnostic technologies of Nymox Pharmaceutical Corporation (Nasdaq: NYMX - news) are highlighted in a special article in the latest issue of Science Magazine, the preeminent scientific publication of the American Association for the Advancement of Science. |
| 10/18/2001 | | | | Nymox NicAlert™ Test Recommended by Tobacco Researchers
topic: Tobacco Exposure Tests
October 18, 2001: The Nymox Pharmaceutical Corporation (NASDAQ: NYMX) NicAlert™ is gaining enthusiastic support from increasing numbers of tobacco researchers and experts. NicAlert™ is an inexpensive, simple-to-use test strip that uses urine or saliva to determine whether a person is using tobacco products. The new product is drawing praise from top researchers. |
| 10/10/2001 | | | | Nymox Enters Strategic Marketing Alliance with Cybear, a Member of the Andrx Corporation
topic: Marketing
October 10, 2001: Nymox Pharmaceutical Corporation announced today that it has entered into a strategic marketing alliance with Cybear Inc., a member of Andrx Corporation (NASDAQ: ADRX). Under the terms of the agreement, Nymox will utilize Cybear's Web portals, including Physicians' Online, as a primary marketing channel for Nymox's AlzheimAlert™ test product. |
| 10/04/2001 | | | | Nymox Website Highly Rated in Web Exposure Report
topic: Marketing
October 4, 2001: Recent statistics show that Nymox Pharmaceutical Corporation ranks among the highest in biotech leaders in web exposure. According to Scrip, based on the U.S. Biotech Website Search Engine Exposure Index, the Nymox website scored 721 points, slightly less than that of Chiron (737) and Serono (805). Nymox ranked behind such biotech industry leaders as Genzyme, Genentech, Amgen, Biogen, and Serono, and ahead of Idec, Nabi, Icos, and Bio-technology General. Nymox's website is at www.nymox.com. Scrip is the world's leading pharmaceutical business newsletter with over 90,000 subscribers drawn from every sector of the world pharmaceutical industry. |
| 09/28/2001 | | | | Nymox Pharmaceutical Corp. to Hold Third Manhattan Alzheimer Disease Conference in November 2001
topic: R&D: Alzheimer's Disease Treatments
September 28, 2001: Nymox Pharmaceutical Corporation is pleased to announce that it will sponsor the Third Manhattan Alzheimer Disease Conference in New York in November 2001. The 2001 Manhattan Conference is planned to have a number of new features and up-to-date concerns presented by a world class assembly of speakers and panelists. The previous Manhattan Alzheimer Conferences sponsored by Nymox in 1998 and 2000 successfully featured world experts presenting new findings in basic science, clinical trials, and a range of topics in ethics, law and social issues. The 2001 conference will be held on November 28 and further details will be made available in the weeks to come. The Conference date was rescheduled in the aftermath of the tragic events of September 11. |
| 09/27/2001 | | | | Nymox's AlzheimAlert™ Test Featured in Current Issues of Nursing and Radiology Periodicals
topic: AlzheimAlert™ & Diagnosis of Alzheimer's Disease
September 27, 2001: Nymox Pharmaceutical Corporation's AlzheimAlert™, its clinical laboratory test that aids physicians in the diagnosis of Alzheimer's disease, is featured in the current issues of two healthcare publications. ASRT Scanner, the official newsmagazine for the more than 90,000 members of the American Society of Radiologic Technologists, describes Nymox's AlzheimAlert™ test as a "promising diagnostic test" available to physicians across the United States in a cover story on Alzheimer's disease. RN, the widely circulated magazine for registered nurses, provides its readers with detailed illustrated product information about AlzheimAlert™. |
| 09/17/2001 | | | | Nymox Pharmaceutical Corporation Makes Donation for the Victims of September 11, 2001
topic: Financial
MAYWOOD, NJ (September 17, 2001) -- Nymox has pledged a $20,000 donation to the Red Cross and the Salvation Army for the needs of victims and their families. |
| 08/17/2001 | | | | Nymox Appoints Dr. Paul A. Kraus as Clinical Consultant
topic: Appointments
MAYWOOD, NJ (August 17, 2001) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the appointment of Paul A. Kraus MD as clinical consultant. Dr. Kraus will be serving in an active advisory role in Nymox's clinical trial activities. |
|